You searched for "cystic"
Ozurdex in epiretinal membrane surgery
5 August 2020
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
This was a prospective multicentre pilot study, looking at the effect of Ozurdex on visual acuity (VA) and central retinal thickness (CRT) in patients undergoing surgery for epiretinal membrane (ERM). Twelve eyes of 12 patients were included in the study....
Topical nonsteroidal ant-inflammatory drugs (NSAIDs) in patients undergoing cataract surgery
4 February 2021
| Kurt Spiteri Cornish
|
EYE - Cataract, EYE - Refractive
|
Postoperative inflammation, cataract surgery, diclofenac, laser flare meter, nepafenac
Inflammation is a major risk factor for the development of cystoid macular oedema (CMO) after cataract surgery, leading to breakdown of the blood-retina barrier. There is a correlation between severity of CMO and level of postoperative inflammation. Laser flare meter...
Complications after cataract surgery in high myopes: a systematic review and meta-analysis
The authors review all the modern literature on complications after phacoemulsification in high myopes with axial lengths (AL) greater than 25.0mm. Twenty-eight studies reporting on 19,586 eyes were included. The corrected distance visual acuity (CDVA) improved from 0.96 ± 0.53...
Evaluation of fluocinolone acetonide in the management of BRC
1 June 2022
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a single-centre, retrospective, intervention study of 15 eyes of birdshot retinochoroiditis (BRC) patients who received Iluvein, with a mean follow-up period of 31 months. Five eyes had previously received dexamethasone intravitreal implant 0.7mg (Ozurdex). Fluorescein angiography (FA) showed...
A closer look at the new wave of glaucoma surgery – radical or old school?
1 October 2016
| Demetrios T Manasses, Leon Au
|
EYE - Glaucoma
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...
The prevalence of macular cysts in patients with clinical cone-rod dystrophy determined by spectral domain optical coherence tomography
1 August 2014
| Huw Edward Oliphant
|
EYE - Vitreo-Retinal
Cone-rod dystrophy is a progressive photoreceptor disorder which has multiple inheritance patterns. It is rare, with a prevalence of 1 in 40,000. Macular cysts are well recognised in other photoreceptor conditions such as retinitis pigments and choroideraemia, while they are...
Pharmacopoeia of the Royal Infirmary of Edinburgh
4 February 2021
| Andrew King
|
EYE - General
The compact volume depicted in Figure 1 bears the simple title Pharmacopoeia. The book originally belonged to the author’s father, the late John King. A pharmacist by profession, John King maintained a keen interest in matters pertaining to pharmaceutical history....
Game show freak
3 April 2023
| Peter Cackett
|
EYE - General
As a child of the 70s and 80s, there were limited television viewing opportunities. For the duration of the 70s there were only three channels, only moving to four with the launch of Channel 4 in 1982. Not only that,...
The results of the last survey Feb24
2 February 2024
| Amar Alwitry
|
EYE - Vitreo-Retinal
Thank you to all those who participated in this edition’s survey and for those of you who attended my recent Medico-legal Seminar at the Royal College of Ophthalmologists. It was a fascinating and educational day, made a success by the...
Investigating the link between corneal clarity and statin use
2 February 2024
| Mohammad Nofal Usman, Nadia L Chaudhry
|
EYE - Cornea
Transparency is a vital attribute of the cornea, necessary in preserving healthy vision. Maintaining this requires the collective input of the various layers of the cornea. Mostly, the layers implicated in this are the corneal stroma and endothelium [1]. Our...
Steroid implants in the treatment of post-epiretinal membrane peel macular oedema
1 February 2018
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
This is a retrospective review of 39 eyes of 37 patients treated with Ozurdex® (intravitreal dexamethasone implant) for persistent post-operative cystoid macular oedema (CMO) following vitrectomy and idiopathic epiretinal membrane (ERM) peeling. The 0.7mg implant was injected in each eye...
Vision loss during Eylea treatment for AMD
1 December 2017
| Saruban Pasu
|
EYE - Vitreo-Retinal
This report investigated patients who lost more than two lines of vision despite periodic injections of aflibercept and explored the factors associated with vision loss. One hundred and ninety-six eyes were included in this study over a two year period....
